|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:FRMD4B-ABCA5 (FusionGDB2 ID:31233) |
Fusion Gene Summary for FRMD4B-ABCA5 |
Fusion gene summary |
Fusion gene information | Fusion gene name: FRMD4B-ABCA5 | Fusion gene ID: 31233 | Hgene | Tgene | Gene symbol | FRMD4B | ABCA5 | Gene ID | 23150 | 23461 |
Gene name | FERM domain containing 4B | ATP binding cassette subfamily A member 5 | |
Synonyms | 6030440G05Rik|GRSP1 | ABC13|EST90625|HTC3 | |
Cytomap | 3p14.1 | 17q24.3 | |
Type of gene | protein-coding | protein-coding | |
Description | FERM domain-containing protein 4BGRP1-binding protein GRSP1 | ATP-binding cassette sub-family A member 5ATP-binding cassette A5ATP-binding cassette, sub-family A (ABC1), member 5 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q9Y2L6 | Q8WWZ7 | |
Ensembl transtripts involved in fusion gene | ENST00000398540, ENST00000542259, ENST00000497757, ENST00000478263, | ENST00000392676, ENST00000392677, ENST00000588877, ENST00000589609, | |
Fusion gene scores | * DoF score | 13 X 10 X 8=1040 | 5 X 6 X 3=90 |
# samples | 14 | 5 | |
** MAII score | log2(14/1040*10)=-2.89308479608349 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/90*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: FRMD4B [Title/Abstract] AND ABCA5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | FRMD4B(69336903)-ABCA5(67252424), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | FRMD4B-ABCA5 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. FRMD4B-ABCA5 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene breakpoints across FRMD4B (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across ABCA5 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SKCM | TCGA-WE-A8ZR-06A | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
ChimerDB4 | SKCM | TCGA-WE-A8ZR-06A | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
ChimerDB4 | SKCM | TCGA-WE-A8ZR-06A | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
Top |
Fusion Gene ORF analysis for FRMD4B-ABCA5 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000398540 | ENST00000392676 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
Frame-shift | ENST00000398540 | ENST00000392677 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
Frame-shift | ENST00000398540 | ENST00000588877 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
5CDS-intron | ENST00000398540 | ENST00000589609 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
In-frame | ENST00000542259 | ENST00000392676 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
In-frame | ENST00000542259 | ENST00000392677 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
In-frame | ENST00000542259 | ENST00000588877 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
5CDS-intron | ENST00000542259 | ENST00000589609 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
intron-3CDS | ENST00000497757 | ENST00000392676 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
intron-3CDS | ENST00000497757 | ENST00000392677 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
intron-3CDS | ENST00000497757 | ENST00000588877 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
intron-intron | ENST00000497757 | ENST00000589609 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
intron-3CDS | ENST00000478263 | ENST00000392676 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
intron-3CDS | ENST00000478263 | ENST00000392677 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
intron-3CDS | ENST00000478263 | ENST00000588877 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
intron-intron | ENST00000478263 | ENST00000589609 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000542259 | FRMD4B | chr3 | 69336903 | - | ENST00000392676 | ABCA5 | chr17 | 67252424 | - | 5215 | 791 | 768 | 1988 | 406 |
ENST00000542259 | FRMD4B | chr3 | 69336903 | - | ENST00000392677 | ABCA5 | chr17 | 67252424 | - | 5091 | 791 | 768 | 1988 | 406 |
ENST00000542259 | FRMD4B | chr3 | 69336903 | - | ENST00000588877 | ABCA5 | chr17 | 67252424 | - | 2575 | 791 | 768 | 1988 | 406 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000542259 | ENST00000392676 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - | 0.00017205 | 0.99982786 |
ENST00000542259 | ENST00000392677 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - | 0.00017278 | 0.9998272 |
ENST00000542259 | ENST00000588877 | FRMD4B | chr3 | 69336903 | - | ABCA5 | chr17 | 67252424 | - | 0.00088445 | 0.9991155 |
Top |
Fusion Genomic Features for FRMD4B-ABCA5 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for FRMD4B-ABCA5 |
Go to FGviewer for the breakpoints of chr3:69336903-chr17:67252424 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
FRMD4B | ABCA5 |
FUNCTION: Member of GRP1 signaling complexes that are acutely recruited to plasma membrane ruffles in response to insulin receptor signaling. May function as a scaffolding protein that regulates epithelial cell polarity by connecting ARF6 activation with the PAR3 complex. Plays a redundant role with FRMD4A in epithelial polarization. {ECO:0000250|UniProtKB:Q920B0}. | FUNCTION: Cholesterol efflux transporter in macrophages that is responsible for APOAI/high-density lipoproteins (HDL) formation at the plasma membrane under high cholesterol levels and participates in reverse cholesterol transport (PubMed:25125465). May play a role in the processing of autolysosomes (By similarity). {ECO:0000250|UniProtKB:Q8K448, ECO:0000269|PubMed:25125465}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 1290_1533 | 1243.6666666666667 | 1643.0 | Domain | ABC transporter 2 | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 1290_1533 | 1243.6666666666667 | 1643.0 | Domain | ABC transporter 2 | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 1333_1340 | 1243.6666666666667 | 1643.0 | Nucleotide binding | ATP 2 | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 1333_1340 | 1243.6666666666667 | 1643.0 | Nucleotide binding | ATP 2 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | FRMD4B | chr3:69336903 | chr17:67252424 | ENST00000398540 | - | 5 | 23 | 417_450 | 167.0 | 1035.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | FRMD4B | chr3:69336903 | chr17:67252424 | ENST00000398540 | - | 5 | 23 | 531_561 | 167.0 | 1035.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | FRMD4B | chr3:69336903 | chr17:67252424 | ENST00000398540 | - | 5 | 23 | 59_361 | 167.0 | 1035.0 | Domain | FERM |
Hgene | FRMD4B | chr3:69336903 | chr17:67252424 | ENST00000398540 | - | 5 | 23 | 542_971 | 167.0 | 1035.0 | Region | Necessary for adherens junction and tight junction localization |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 478_713 | 1243.6666666666667 | 1643.0 | Domain | ABC transporter 1 | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 478_713 | 1243.6666666666667 | 1643.0 | Domain | ABC transporter 1 | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 514_521 | 1243.6666666666667 | 1643.0 | Nucleotide binding | ATP 1 | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 514_521 | 1243.6666666666667 | 1643.0 | Nucleotide binding | ATP 1 | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 1021_1041 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 1071_1091 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 1102_1122 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 1139_1159 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 1169_1189 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 1207_1227 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 220_240 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 264_284 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 297_317 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 328_348 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 32_52 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 355_375 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 396_416 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 866_886 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000392676 | 27 | 39 | 967_987 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 1021_1041 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 1071_1091 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 1102_1122 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 1139_1159 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 1169_1189 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 1207_1227 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 220_240 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 264_284 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 297_317 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 328_348 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 32_52 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 355_375 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 396_416 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 866_886 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical | |
Tgene | ABCA5 | chr3:69336903 | chr17:67252424 | ENST00000588877 | 26 | 38 | 967_987 | 1243.6666666666667 | 1643.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for FRMD4B-ABCA5 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000542259_ENST00000392676_TCGA-WE-A8ZR-06A_FRMD4B_chr3_69336903_-_ABCA5_chr17_67252424_length(transcript)=5215nt_BP=791nt CGAGGGCCAGCTTGGTGGAGCTTAGCACAGCTTGCTCGGCGCTGCGAGCGGGCGGGGGTGGACACTGGGCTTCTGTGTGCCAGTCGCAGC CGTTGGCTGGCGGGCACCCAATCCCAGGGCATGCCGCCGGAGCCTGGCCAGGACGCACGGTGAAAGACGAGTTTGGTGGCAGGCTTGACC CCCCGGCTGCCAGCAGAAGCCGGCGTCGGGAGCCCAGGCGGGCAGGCCGCTGGGGTCGGGGCTGCACGTACGAGAGCCGGGACGCCCGGG TTCAGAGCGAAGGAGGAGGCATGGCTTCGGTGTTCATGTGTGGCGTGGAGGACCTGCTGTTCAGCGGCAGCCGCTTCGTATGGAACTTGA CCGTGTCCACGCTGCGGAGATGGTACACGGAGAGGCTGCGGGCTTGCCACCAGGTGCTGCGGACGTGGTGCGGGCTGCAGGACGTGTACC AGATGACAGAAGGCAGGCACTGCCAGGTGCACCTCCTGGATGATAGGAGACTGGAGCTGCTGGTTCAGCCCAAACTTCTAGCAAGAGAGT TGCTGGACCTAGTGGCTTCACATTTCAACCTGAAAGAAAAGGAGTATTTTGGAATAACATTCATAGATGACACAGGTCAGCAGAACTGGC TGCAGTTAGATCACCGAGTTCTTGACCACGATTTGCCCAAGAAACCAGGCCCAACCATTTTGCACTTTGCTGTGAGGTTTTACATTGAGA GCATATCGTTTTTAAAGGATAAAACCACCGTGGAGCTGTTTTTCCTGAATGCAAAGGCCTGTGTGCACAAGAAACCTTTCAACGAAGTCT AAAAATAGGAAGCTTCCAGAACCACCAGACAATGAGGATGAAGATGAAGATGTCAAAGCTGAAAGACTAAAGGTCAAAGAGCTGATGGGT TGCCAGTGTTGTGAGGAGAAACCATCCATTATGGTCAGCAATTTGCATAAAGAATATGATGACAAGAAAGATTTTCTTCTTTCAAGAAAA GTAAAGAAAGTGGCAACTAAATACATCTCTTTCTGTGTGAAAAAAGGAGAGATCTTAGGACTATTGGGTCCAAATGGTGCTGGCAAAAGC ACAATTATTAATATTCTGGTTGGTGATATTGAACCAACTTCAGGCCAGGTATTTTTAGGAGATTATTCTTCAGAGACAAGTGAAGATGAT GATTCACTGAAGTGTATGGGTTACTGTCCTCAGATAAACCCTTTGTGGCCAGATACTACATTGCAGGAACATTTTGAAATTTATGGAGCT GTCAAAGGAATGAGTGCAAGTGACATGAAAGAAGTCATAAGTCGAATAACACATGCACTTGATTTAAAAGAACATCTTCAGAAGACTGTA AAGAAACTACCTGCAGGAATCAAACGAAAGTTGTGTTTTGCTCTAAGTATGCTAGGGAATCCTCAGATTACTTTGCTAGATGAACCATCT ACAGGTATGGATCCCAAAGCCAAACAGCACATGTGGCGAGCAATTCGAACTGCATTTAAAAACAGAAAGCGGGCTGCTATTCTGACCACT CACTATATGGAGGAGGCAGAGGCTGTCTGTGATCGAGTAGCTATCATGGTGTCTGGGCAGTTAAGATGTATCGGAACAGTACAACATCTA AAGAGTAAATTTGGAAAAGGCTACTTTTTGGAAATTAAATTGAAGGACTGGATAGAAAACCTAGAAGTAGACCGCCTTCAAAGAGAAATT CAGTATATTTTCCCAAATGCAAGCCGTCAGGAAAGTTTTTCTTCTATTTTGGCTTATAAAATTCCTAAGGAAGATGTTCAGTCCCTTTCA CAATCTTTTTTTAAGCTGGAAGAAGCTAAACATGCTTTTGCCATTGAAGAATATAGCTTTTCTCAAGCAACATTGGAACAGGTTTTTGTA GAACTCACTAAAGAACAAGAGGAGGAAGATAATAGTTGTGGAACTTTAAACAGCACACTTTGGTGGGAACGAACACAAGAAGATAGAGTA GTATTTTGAATTTGTATTGTTCGGTCTGCTTACTGGGACTTCTTTCTTTTTCACTTAATTTTAACTTTGGTTTAAAAAGTTTTTTATTGG AATGGTAACTGGAGAACCAAGAACGCACTTGAAATTTTTCTAAGCTCCTTAATTGAAATGCTGTGGTTGTGTGTTTTGCTTTTCTTTAAA TAAAACGTATGTATAATTAAGTGAAGCTGCATGTTTGTATTGAAGTATATTGAACTATATAGTTTGTATGTCATCTTTTTCACCATTCAG AAACAGTGCTTCTGAATTTGTGATTTAAAGGAATTGTAATAGAATAGTTTTATTTTTAAGTTATCTTTAAGTTTATGCCATCTTCTTAAA TAAGTACGTAATGTTCCAATCTAAATAAAAAACTAATTCATAACTAATGCATAGAAAAGATACATAAAGCAATGTGAAAGTTTCTTGCTT CTCCTTTTTAATTTCTAAAAAAGCCACTTTGAATGGAAGTTGTCATCCGTAAAAGCTGAAGTGTAAGCACTAGGAAATCTCAATATAGAG ATTTGAGGAAAGTTATATCCACTAGGTGGCAGTCATTGATCATAATAAGTGAAATGAGCCCTTGTTCTAGTACATGATTTTAGGCTTAGG TAATTAGGTATGTGAAATTACATTTCTTTAATTTAAAGTAAAATTCAGAAGGTTTTAGTTATTATAATTAAAGGAAGACTGTGTGTAGAA TCTTACGTAATAGTCTGATTCTTTGACTCTGTGGCTAGAATGACAGTTATCTATGGAGGTGGTAGAATTAAGCCATACCTTTTCCTTCAT CACTCTTGGAACATATAAATTTTTTGTCATCTTCCTTGCAAAGGGCACATTTAATTTTGTTCTTGAATAAAATATTTTATTGGGTATTTG TTTTTATTGGTAAACTTTAGTGAATCTCTTCTATAAAATTGTAAGTAGATCAGTGTGTAGATTTATTTAGTAACTTACCTCATTGACTTT GGAACATGGTAGGATATGAATAAACTCTTTCAAGGGTTAAATTAAGAATTGTAAGTGCAGTGCGCCTATTTCTTTTTAATAAGAACCAGA ATTTCATTTTTGATAGAGTTAAAGGCATGGCTAATATTTTCTTAGAAATACTTCCTTGTACAACCCATGTATTGGCTCAAGGTATAAAAT AGTGTAAATAATGCTAGTTGACATTACATTTCAACCAAATGAAAGTATTAACTTCATAAAACAAATATATTGAGAGTGTGATTATTGTAT TAGACAACAACAACAGCAATGACAGAAGGATTTGGTACTGAATTACTTTAAATAAGCAAAACCTTTCAGTGGCATTATTCATTCTTTAAT GTAGGCAAAATTTAATGAACTTTTAGCTTTATTGTGTAATAAGACATCTGTGATTTTAGGCTCTAGCAGTGGATTTAAAAGTGTTCTTTC TCGGTACAAAGTACGTGGCTGATATTTTCCCCCATTGCTGGGGGCAGTTGCTATACACTTTCCTAAAGTATATATAATGTTCACATAAAT ACCCAGGGACCTCTTTTTTGGGATGTGCTTTTGTAATTATGTGTAACCTTGAATACTTAAGTTTAGTAAAAGCAACAAAATTATATCTAT AGTTTACTAAGGCAGTCACGAAAAAGCATAGTTTTTTTTAGAACCTGACCATCCTAAGAAAGTTATGTCATCTGAAGATAGAGCATGACT AATGAAGAAAATTACCTGCTTTTGCACGTAGATTTGGTAACTTTCACTTTACATTTGTGAATGTGTAATTGGTGCAAAGTAAATTTTTTT TCCTGCAAAGTGAAAGTTGAGTAGTCACAATCATGTTATTTATTTTGTTCATTTAGTTACTTTGCTTTTAATGTATATGAATACATGCTC TTGTAAACAATTTTAAAAGACATTCAAATTTTTTTTTAGTTTTTATATACTCAGAATATATTTTGGTTGTTAAATTAAATTATGTTCCCT TTTTCACAGTAACAAAATCTGACTCAGGAGAAATATAACTTAATTCTTAGGAAAACAAGGGTAAGTGAGCTGGAAAGCAAAGGAGGCAAA AAGTGAAATATATTTATTTACAGTGTACAGTTCATGTTTATGAACATACTAATTTTAAAATGTCTTAAATTACTGATCTCAAAACTTTTT TCTATGTCAGTACAGATAAATAAATAAATATACATATTAGGCAAAAGCAACATCACCAACCTTATATTTCCCATTCATGGTCAAATTTTC AAAGGAAAGTAAAAGCTGAGCTTTACTGAGTGAGTGTTTACTGACTAATAAGGCAAGAAAAAACATGATGAGTGTACTTTACATCTTACT TTTGTGGGCTCTTAATTTTTTTCTCTAGTTTGTTTTCAGTAAAGACAGTGGGTTTTCTTTAAAATAATTTTTTTCTTTTAAATTTGCACA AATTATCTTAGGTCAGTATTTTGGTTTTAATCATTAAAACATTTTTAGAGTAATGTAATTTAACAAATATTTTAAGTGATTATGTTTCCA GAAATGGATTCTTTGGAGAGAACTCGGATGACTATCAGTTTTGGCCCTGTAAGATCGTGGAGATCTGTAAGATAGATACTTATATAACTT ACATAAAATATATATAATATATTACTTATATAACTTATATAACTAGCTATTATTTTATATAACTAACTATAATATGACAAATCCTTTGCT AGTAGTACTAACAACGTTTTATAGGAGCACAATTAATTTTACTTAGGATAAGTGTTGTTATTATTGTTTTTATTGTTGTTCTGTTAGTTA CTCAAAACTTCATTCTAATTGTGCCCTGAGTTTGTTAAAATACCATACTGTATTTTTGTGTAACATGTAAATAGGCATTAATTTTTGAGA AATAGAAATGTTTATCCTTAATGTATTTTTAATTTGCTAACATTGATTTTTTATTTTCTTTCCTGAAATAGCTTATTTCCTAAAATGAAA GAATTTATTCTCAGATGAATAATTTTTATATCAGCTATTCTTATCAGGTAAAAGTTTAATTATTTTTTATTTATAATATATGTAAGCAAT TCTCAATGCTGCTCTTTAAGAAAAATAAATATGATTATATTAATAATAAGCTTTAAGAGTTGAAAATTTAAGACAAGTCATTTTGTATAC >In-frame_ENST00000542259_ENST00000392676_TCGA-WE-A8ZR-06A_FRMD4B_chr3_69336903_-_ABCA5_chr17_67252424_length(amino acids)=406AA_start in transcript=768_stop in transcript=1988 MQRPVCTRNLSTKSKNRKLPEPPDNEDEDEDVKAERLKVKELMGCQCCEEKPSIMVSNLHKEYDDKKDFLLSRKVKKVATKYISFCVKKG EILGLLGPNGAGKSTIINILVGDIEPTSGQVFLGDYSSETSEDDDSLKCMGYCPQINPLWPDTTLQEHFEIYGAVKGMSASDMKEVISRI THALDLKEHLQKTVKKLPAGIKRKLCFALSMLGNPQITLLDEPSTGMDPKAKQHMWRAIRTAFKNRKRAAILTTHYMEEAEAVCDRVAIM VSGQLRCIGTVQHLKSKFGKGYFLEIKLKDWIENLEVDRLQREIQYIFPNASRQESFSSILAYKIPKEDVQSLSQSFFKLEEAKHAFAIE -------------------------------------------------------------- >In-frame_ENST00000542259_ENST00000392677_TCGA-WE-A8ZR-06A_FRMD4B_chr3_69336903_-_ABCA5_chr17_67252424_length(transcript)=5091nt_BP=791nt CGAGGGCCAGCTTGGTGGAGCTTAGCACAGCTTGCTCGGCGCTGCGAGCGGGCGGGGGTGGACACTGGGCTTCTGTGTGCCAGTCGCAGC CGTTGGCTGGCGGGCACCCAATCCCAGGGCATGCCGCCGGAGCCTGGCCAGGACGCACGGTGAAAGACGAGTTTGGTGGCAGGCTTGACC CCCCGGCTGCCAGCAGAAGCCGGCGTCGGGAGCCCAGGCGGGCAGGCCGCTGGGGTCGGGGCTGCACGTACGAGAGCCGGGACGCCCGGG TTCAGAGCGAAGGAGGAGGCATGGCTTCGGTGTTCATGTGTGGCGTGGAGGACCTGCTGTTCAGCGGCAGCCGCTTCGTATGGAACTTGA CCGTGTCCACGCTGCGGAGATGGTACACGGAGAGGCTGCGGGCTTGCCACCAGGTGCTGCGGACGTGGTGCGGGCTGCAGGACGTGTACC AGATGACAGAAGGCAGGCACTGCCAGGTGCACCTCCTGGATGATAGGAGACTGGAGCTGCTGGTTCAGCCCAAACTTCTAGCAAGAGAGT TGCTGGACCTAGTGGCTTCACATTTCAACCTGAAAGAAAAGGAGTATTTTGGAATAACATTCATAGATGACACAGGTCAGCAGAACTGGC TGCAGTTAGATCACCGAGTTCTTGACCACGATTTGCCCAAGAAACCAGGCCCAACCATTTTGCACTTTGCTGTGAGGTTTTACATTGAGA GCATATCGTTTTTAAAGGATAAAACCACCGTGGAGCTGTTTTTCCTGAATGCAAAGGCCTGTGTGCACAAGAAACCTTTCAACGAAGTCT AAAAATAGGAAGCTTCCAGAACCACCAGACAATGAGGATGAAGATGAAGATGTCAAAGCTGAAAGACTAAAGGTCAAAGAGCTGATGGGT TGCCAGTGTTGTGAGGAGAAACCATCCATTATGGTCAGCAATTTGCATAAAGAATATGATGACAAGAAAGATTTTCTTCTTTCAAGAAAA GTAAAGAAAGTGGCAACTAAATACATCTCTTTCTGTGTGAAAAAAGGAGAGATCTTAGGACTATTGGGTCCAAATGGTGCTGGCAAAAGC ACAATTATTAATATTCTGGTTGGTGATATTGAACCAACTTCAGGCCAGGTATTTTTAGGAGATTATTCTTCAGAGACAAGTGAAGATGAT GATTCACTGAAGTGTATGGGTTACTGTCCTCAGATAAACCCTTTGTGGCCAGATACTACATTGCAGGAACATTTTGAAATTTATGGAGCT GTCAAAGGAATGAGTGCAAGTGACATGAAAGAAGTCATAAGTCGAATAACACATGCACTTGATTTAAAAGAACATCTTCAGAAGACTGTA AAGAAACTACCTGCAGGAATCAAACGAAAGTTGTGTTTTGCTCTAAGTATGCTAGGGAATCCTCAGATTACTTTGCTAGATGAACCATCT ACAGGTATGGATCCCAAAGCCAAACAGCACATGTGGCGAGCAATTCGAACTGCATTTAAAAACAGAAAGCGGGCTGCTATTCTGACCACT CACTATATGGAGGAGGCAGAGGCTGTCTGTGATCGAGTAGCTATCATGGTGTCTGGGCAGTTAAGATGTATCGGAACAGTACAACATCTA AAGAGTAAATTTGGAAAAGGCTACTTTTTGGAAATTAAATTGAAGGACTGGATAGAAAACCTAGAAGTAGACCGCCTTCAAAGAGAAATT CAGTATATTTTCCCAAATGCAAGCCGTCAGGAAAGTTTTTCTTCTATTTTGGCTTATAAAATTCCTAAGGAAGATGTTCAGTCCCTTTCA CAATCTTTTTTTAAGCTGGAAGAAGCTAAACATGCTTTTGCCATTGAAGAATATAGCTTTTCTCAAGCAACATTGGAACAGGTTTTTGTA GAACTCACTAAAGAACAAGAGGAGGAAGATAATAGTTGTGGAACTTTAAACAGCACACTTTGGTGGGAACGAACACAAGAAGATAGAGTA GTATTTTGAATTTGTATTGTTCGGTCTGCTTACTGGGACTTCTTTCTTTTTCACTTAATTTTAACTTTGGTTTAAAAAGTTTTTTATTGG AATGGTAACTGGAGAACCAAGAACGCACTTGAAATTTTTCTAAGCTCCTTAATTGAAATGCTGTGGTTGTGTGTTTTGCTTTTCTTTAAA TAAAACGTATGTATAATTAAGTGAAGCTGCATGTTTGTATTGAAGTATATTGAACTATATAGTTTGTATGTCATCTTTTTCACCATTCAG AAACAGTGCTTCTGAATTTGTGATTTAAAGGAATTGTAATAGAATAGTTTTATTTTTAAGTTATCTTTAAGTTTATGCCATCTTCTTAAA TAAGTACGTAATGTTCCAATCTAAATAAAAAACTAATTCATAACTAATGCATAGAAAAGATACATAAAGCAATGTGAAAGTTTCTTGCTT CTCCTTTTTAATTTCTAAAAAAGCCACTTTGAATGGAAGTTGTCATCCGTAAAAGCTGAAGTGTAAGCACTAGGAAATCTCAATATAGAG ATTTGAGGAAAGTTATATCCACTAGGTGGCAGTCATTGATCATAATAAGTGAAATGAGCCCTTGTTCTAGTACATGATTTTAGGCTTAGG TAATTAGGTATGTGAAATTACATTTCTTTAATTTAAAGTAAAATTCAGAAGGTTTTAGTTATTATAATTAAAGGAAGACTGTGTGTAGAA TCTTACGTAATAGTCTGATTCTTTGACTCTGTGGCTAGAATGACAGTTATCTATGGAGGTGGTAGAATTAAGCCATACCTTTTCCTTCAT CACTCTTGGAACATATAAATTTTTTGTCATCTTCCTTGCAAAGGGCACATTTAATTTTGTTCTTGAATAAAATATTTTATTGGGTATTTG TTTTTATTGGTAAACTTTAGTGAATCTCTTCTATAAAATTGTAAGTAGATCAGTGTGTAGATTTATTTAGTAACTTACCTCATTGACTTT GGAACATGGTAGGATATGAATAAACTCTTTCAAGGGTTAAATTAAGAATTGTAAGTGCAGTGCGCCTATTTCTTTTTAATAAGAACCAGA ATTTCATTTTTGATAGAGTTAAAGGCATGGCTAATATTTTCTTAGAAATACTTCCTTGTACAACCCATGTATTGGCTCAAGGTATAAAAT AGTGTAAATAATGCTAGTTGACATTACATTTCAACCAAATGAAAGTATTAACTTCATAAAACAAATATATTGAGAGTGTGATTATTGTAT TAGACAACAACAACAGCAATGACAGAAGGATTTGGTACTGAATTACTTTAAATAAGCAAAACCTTTCAGTGGCATTATTCATTCTTTAAT GTAGGCAAAATTTAATGAACTTTTAGCTTTATTGTGTAATAAGACATCTGTGATTTTAGGCTCTAGCAGTGGATTTAAAAGTGTTCTTTC TCGGTACAAAGTACGTGGCTGATATTTTCCCCCATTGCTGGGGGCAGTTGCTATACACTTTCCTAAAGTATATATAATGTTCACATAAAT ACCCAGGGACCTCTTTTTTGGGATGTGCTTTTGTAATTATGTGTAACCTTGAATACTTAAGTTTAGTAAAAGCAACAAAATTATATCTAT AGTTTACTAAGGCAGTCACGAAAAAGCATAGTTTTTTTTAGAACCTGACCATCCTAAGAAAGTTATGTCATCTGAAGATAGAGCATGACT AATGAAGAAAATTACCTGCTTTTGCACGTAGATTTGGTAACTTTCACTTTACATTTGTGAATGTGTAATTGGTGCAAAGTAAATTTTTTT TCCTGCAAAGTGAAAGTTGAGTAGTCACAATCATGTTATTTATTTTGTTCATTTAGTTACTTTGCTTTTAATGTATATGAATACATGCTC TTGTAAACAATTTTAAAAGACATTCAAATTTTTTTTTAGTTTTTATATACTCAGAATATATTTTGGTTGTTAAATTAAATTATGTTCCCT TTTTCACAGTAACAAAATCTGACTCAGGAGAAATATAACTTAATTCTTAGGAAAACAAGGGTAAGTGAGCTGGAAAGCAAAGGAGGCAAA AAGTGAAATATATTTATTTACAGTGTACAGTTCATGTTTATGAACATACTAATTTTAAAATGTCTTAAATTACTGATCTCAAAACTTTTT TCTATGTCAGTACAGATAAATAAATAAATATACATATTAGGCAAAAGCAACATCACCAACCTTATATTTCCCATTCATGGTCAAATTTTC AAAGGAAAGTAAAAGCTGAGCTTTACTGAGTGAGTGTTTACTGACTAATAAGGCAAGAAAAAACATGATGAGTGTACTTTACATCTTACT TTTGTGGGCTCTTAATTTTTTTCTCTAGTTTGTTTTCAGTAAAGACAGTGGGTTTTCTTTAAAATAATTTTTTTCTTTTAAATTTGCACA AATTATCTTAGGTCAGTATTTTGGTTTTAATCATTAAAACATTTTTAGAGTAATGTAATTTAACAAATATTTTAAGTGATTATGTTTCCA GAAATGGATTCTTTGGAGAGAACTCGGATGACTATCAGTTTTGGCCCTGTAAGATCGTGGAGATCTGTAAGATAGATACTTATATAACTT ACATAAAATATATATAATATATTACTTATATAACTTATATAACTAGCTATTATTTTATATAACTAACTATAATATGACAAATCCTTTGCT AGTAGTACTAACAACGTTTTATAGGAGCACAATTAATTTTACTTAGGATAAGTGTTGTTATTATTGTTTTTATTGTTGTTCTGTTAGTTA CTCAAAACTTCATTCTAATTGTGCCCTGAGTTTGTTAAAATACCATACTGTATTTTTGTGTAACATGTAAATAGGCATTAATTTTTGAGA AATAGAAATGTTTATCCTTAATGTATTTTTAATTTGCTAACATTGATTTTTTATTTTCTTTCCTGAAATAGCTTATTTCCTAAAATGAAA GAATTTATTCTCAGATGAATAATTTTTATATCAGCTATTCTTATCAGGTAAAAGTTTAATTATTTTTTATTTATAATATATGTAAGCAAT >In-frame_ENST00000542259_ENST00000392677_TCGA-WE-A8ZR-06A_FRMD4B_chr3_69336903_-_ABCA5_chr17_67252424_length(amino acids)=406AA_start in transcript=768_stop in transcript=1988 MQRPVCTRNLSTKSKNRKLPEPPDNEDEDEDVKAERLKVKELMGCQCCEEKPSIMVSNLHKEYDDKKDFLLSRKVKKVATKYISFCVKKG EILGLLGPNGAGKSTIINILVGDIEPTSGQVFLGDYSSETSEDDDSLKCMGYCPQINPLWPDTTLQEHFEIYGAVKGMSASDMKEVISRI THALDLKEHLQKTVKKLPAGIKRKLCFALSMLGNPQITLLDEPSTGMDPKAKQHMWRAIRTAFKNRKRAAILTTHYMEEAEAVCDRVAIM VSGQLRCIGTVQHLKSKFGKGYFLEIKLKDWIENLEVDRLQREIQYIFPNASRQESFSSILAYKIPKEDVQSLSQSFFKLEEAKHAFAIE -------------------------------------------------------------- >In-frame_ENST00000542259_ENST00000588877_TCGA-WE-A8ZR-06A_FRMD4B_chr3_69336903_-_ABCA5_chr17_67252424_length(transcript)=2575nt_BP=791nt CGAGGGCCAGCTTGGTGGAGCTTAGCACAGCTTGCTCGGCGCTGCGAGCGGGCGGGGGTGGACACTGGGCTTCTGTGTGCCAGTCGCAGC CGTTGGCTGGCGGGCACCCAATCCCAGGGCATGCCGCCGGAGCCTGGCCAGGACGCACGGTGAAAGACGAGTTTGGTGGCAGGCTTGACC CCCCGGCTGCCAGCAGAAGCCGGCGTCGGGAGCCCAGGCGGGCAGGCCGCTGGGGTCGGGGCTGCACGTACGAGAGCCGGGACGCCCGGG TTCAGAGCGAAGGAGGAGGCATGGCTTCGGTGTTCATGTGTGGCGTGGAGGACCTGCTGTTCAGCGGCAGCCGCTTCGTATGGAACTTGA CCGTGTCCACGCTGCGGAGATGGTACACGGAGAGGCTGCGGGCTTGCCACCAGGTGCTGCGGACGTGGTGCGGGCTGCAGGACGTGTACC AGATGACAGAAGGCAGGCACTGCCAGGTGCACCTCCTGGATGATAGGAGACTGGAGCTGCTGGTTCAGCCCAAACTTCTAGCAAGAGAGT TGCTGGACCTAGTGGCTTCACATTTCAACCTGAAAGAAAAGGAGTATTTTGGAATAACATTCATAGATGACACAGGTCAGCAGAACTGGC TGCAGTTAGATCACCGAGTTCTTGACCACGATTTGCCCAAGAAACCAGGCCCAACCATTTTGCACTTTGCTGTGAGGTTTTACATTGAGA GCATATCGTTTTTAAAGGATAAAACCACCGTGGAGCTGTTTTTCCTGAATGCAAAGGCCTGTGTGCACAAGAAACCTTTCAACGAAGTCT AAAAATAGGAAGCTTCCAGAACCACCAGACAATGAGGATGAAGATGAAGATGTCAAAGCTGAAAGACTAAAGGTCAAAGAGCTGATGGGT TGCCAGTGTTGTGAGGAGAAACCATCCATTATGGTCAGCAATTTGCATAAAGAATATGATGACAAGAAAGATTTTCTTCTTTCAAGAAAA GTAAAGAAAGTGGCAACTAAATACATCTCTTTCTGTGTGAAAAAAGGAGAGATCTTAGGACTATTGGGTCCAAATGGTGCTGGCAAAAGC ACAATTATTAATATTCTGGTTGGTGATATTGAACCAACTTCAGGCCAGGTATTTTTAGGAGATTATTCTTCAGAGACAAGTGAAGATGAT GATTCACTGAAGTGTATGGGTTACTGTCCTCAGATAAACCCTTTGTGGCCAGATACTACATTGCAGGAACATTTTGAAATTTATGGAGCT GTCAAAGGAATGAGTGCAAGTGACATGAAAGAAGTCATAAGTCGAATAACACATGCACTTGATTTAAAAGAACATCTTCAGAAGACTGTA AAGAAACTACCTGCAGGAATCAAACGAAAGTTGTGTTTTGCTCTAAGTATGCTAGGGAATCCTCAGATTACTTTGCTAGATGAACCATCT ACAGGTATGGATCCCAAAGCCAAACAGCACATGTGGCGAGCAATTCGAACTGCATTTAAAAACAGAAAGCGGGCTGCTATTCTGACCACT CACTATATGGAGGAGGCAGAGGCTGTCTGTGATCGAGTAGCTATCATGGTGTCTGGGCAGTTAAGATGTATCGGAACAGTACAACATCTA AAGAGTAAATTTGGAAAAGGCTACTTTTTGGAAATTAAATTGAAGGACTGGATAGAAAACCTAGAAGTAGACCGCCTTCAAAGAGAAATT CAGTATATTTTCCCAAATGCAAGCCGTCAGGAAAGTTTTTCTTCTATTTTGGCTTATAAAATTCCTAAGGAAGATGTTCAGTCCCTTTCA CAATCTTTTTTTAAGCTGGAAGAAGCTAAACATGCTTTTGCCATTGAAGAATATAGCTTTTCTCAAGCAACATTGGAACAGGTTTTTGTA GAACTCACTAAAGAACAAGAGGAGGAAGATAATAGTTGTGGAACTTTAAACAGCACACTTTGGTGGGAACGAACACAAGAAGATAGAGTA GTATTTTGAATTTGTATTGTTCGGTCTGCTTACTGGGACTTCTTTCTTTTTCACTTAATTTTAACTTTGGTTTAAAAAGTTTTTTATTGG AATGGTAACTGGAGAACCAAGAACGCACTTGAAATTTTTCTAAGCTCCTTAATTGAAATGCTGTGGTTGTGTGTTTTGCTTTTCTTTAAA TAAAACGTATGTATAATTAAGTGAAGCTGCATGTTTGTATTGAAGTATATTGAACTATATAGTTTGTATGTCATCTTTTTCACCATTCAG AAACAGTGCTTCTGAATTTGTGATTTAAAGGAATTGTAATAGAATAGTTTTATTTTTAAGTTATCTTTAAGTTTATGCCATCTTCTTAAA TAAGTACGTAATGTTCCAATCTAAATAAAAAACTAATTCATAACTAATGCATAGAAAAGATACATAAAGCAATGTGAAAGTTTCTTGCTT CTCCTTTTTAATTTCTAAAAAAGCCACTTTGAATGGAAGTTGTCATCCGTAAAAGCTGAAGTGTAAGCACTAGGAAATCTCAATATAGAG >In-frame_ENST00000542259_ENST00000588877_TCGA-WE-A8ZR-06A_FRMD4B_chr3_69336903_-_ABCA5_chr17_67252424_length(amino acids)=406AA_start in transcript=768_stop in transcript=1988 MQRPVCTRNLSTKSKNRKLPEPPDNEDEDEDVKAERLKVKELMGCQCCEEKPSIMVSNLHKEYDDKKDFLLSRKVKKVATKYISFCVKKG EILGLLGPNGAGKSTIINILVGDIEPTSGQVFLGDYSSETSEDDDSLKCMGYCPQINPLWPDTTLQEHFEIYGAVKGMSASDMKEVISRI THALDLKEHLQKTVKKLPAGIKRKLCFALSMLGNPQITLLDEPSTGMDPKAKQHMWRAIRTAFKNRKRAAILTTHYMEEAEAVCDRVAIM VSGQLRCIGTVQHLKSKFGKGYFLEIKLKDWIENLEVDRLQREIQYIFPNASRQESFSSILAYKIPKEDVQSLSQSFFKLEEAKHAFAIE -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for FRMD4B-ABCA5 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for FRMD4B-ABCA5 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for FRMD4B-ABCA5 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | FRMD4B | C0004238 | Atrial Fibrillation | 2 | CTD_human |
Hgene | FRMD4B | C0235480 | Paroxysmal atrial fibrillation | 2 | CTD_human |
Hgene | FRMD4B | C2585653 | Persistent atrial fibrillation | 2 | CTD_human |
Hgene | FRMD4B | C3468561 | familial atrial fibrillation | 2 | CTD_human |
Tgene | ABCA5 | C0009402 | Colorectal Carcinoma | 1 | CTD_human |
Tgene | ABCA5 | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
Tgene | ABCA5 | C1851120 | Hypertrichosis Terminalis, Generalized, with or without Gingival Hyperplasia | 1 | CTD_human;ORPHANET |